Ken Griffin Intercure Ltd. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$1.18 - $2.71 $236 - $542	-200 Reduced 40.0%	300 $0
Q4 2023 Feb 14, 2024	SELL	$1.01 - $1.62 $1,616 - $2,592	-1,600 Reduced 76.19%	500 $0
Q3 2023 Nov 14, 2023	SELL	$1.39 - $1.72 $2,502 - $3,096	-1,800 Reduced 46.15%	2,100 $3,000
Q2 2023 Aug 14, 2023	BUY	$1.7 - $2.6 $1,530 - $2,340	900 Added 30.0%	3,900 $6,000
Q1 2023 May 15, 2023	BUY	$1.81 - $4.0 $5,430 - $12,000	3,000 New	3,000 $6,000

4.34M

16.9K

300

Ticker INCR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,133,900
Market Cap $103M
Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.